NCT05411757 2022-06-09IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver CancerShandong Public Health Clinical CenterPhase EARLY_PHASE1 Unknown12 enrolled